Market closed
SurModics/$SRDX
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About SurModics
Surmodics Inc is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The company's reportable segments are; Medical Device and In Vitro Diagnostics. Maximum revenue for the company is derived from its Medical Device segment which is involved in the manufacturing and licensing of performance coatings, including surface modification coating technologies and drug-delivery coating technologies. This segment also manufactures vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. Geographically, the company derives key revenue from its domestic market.
Ticker
$SRDX
Sector
Trading on
Industry
Health Care Equipment & Supplies
Headquarters
Employees
389
Website
SurModics Metrics
BasicAdvanced
$498M
-
-$1.02
1.20
-
Price and volume
Market cap
$498M
Beta
1.2
52-week high
$42.44
52-week low
$25.17
Average daily volume
335K
Financial strength
Current ratio
5.449
Quick ratio
3.996
Long term debt to equity
26.475
Total debt to equity
26.475
Interest coverage (TTM)
-0.51%
Management effectiveness
Return on assets (TTM)
-0.66%
Return on equity (TTM)
-12.32%
Valuation
Price to revenue (TTM)
3.941
Price to book
4.46
Price to tangible book (TTM)
10.36
Price to free cash flow (TTM)
-256.41
Growth
Revenue change (TTM)
-9.23%
Earnings per share change (TTM)
-363.42%
3-year revenue growth (CAGR)
5.83%
3-year earnings per share growth (CAGR)
103.66%
What the Analysts think about SurModics
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for SurModics stock.
SurModics Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
SurModics Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for SurModics stock?
SurModics (SRDX) has a market cap of $498M as of February 25, 2025.
What is the P/E ratio for SurModics stock?
The price to earnings (P/E) ratio for SurModics (SRDX) stock is 0 as of February 25, 2025.
Does SurModics stock pay dividends?
No, SurModics (SRDX) stock does not pay dividends to its shareholders as of February 25, 2025.
When is the next SurModics dividend payment date?
SurModics (SRDX) stock does not pay dividends to its shareholders.
What is the beta indicator for SurModics?
SurModics (SRDX) has a beta rating of 1.2. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.